Evidence map›Paper›PMID 24185611›Full record

ArticleHuman genetics2014

A genome-wide association study of prostate cancer in West African men.

Michael Blaise Cook, Zhaoming Wang, Edward D Yeboah, Yao Tettey, Richard B Biritwum, Andrew A Adjei, Evelyn Tay, Ann Truelove, Shelley Niwa, Charles C Chung and 11 more

Erratum issuedAbstract read
In one paragraph

Article in Human genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 64 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 6 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 6 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Advances in Prostate Cancer Biomarkers and Probes.Cyborg and bionic systems (Washington, D.C.) · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Race and prostate cancer: genomic landscape.Nature reviews. Urology · 2022
    Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

21 authors at 10 institutions in 2 countries.

Michael Blaise CookDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Rm 7-E106, MSC 9774, Bethesda, MD, 20892-9774, USA, cookmich@mail.nih.gov.
Zhaoming Wang
Edward D Yeboah
Yao Tettey
Richard B Biritwum
Andrew A Adjei
Evelyn Tay
Ann Truelove
Shelley Niwa
Charles C Chung
Annand P Chokkalingam
Lisa W Chu
Meredith Yeager
Amy Hutchinson
Kai Yu
Kristin A Rand
Christopher A Haiman
African Ancestry Prostate Cancer GWAS Consortium
Robert N Hoover
Ann W Hsing
Stephen J Chanock
Division of Cancer Epidemiology and GeneticsUnited States Department of Health and Human Services · USUniversity of Ghana · GHKorle Bu Teaching Hospital · GHNational Cancer Institute · USUniversity of Southern California · USWestat (United States) · USCancer Prevention Institute of California · USStanford Medicine · USUniversity of California, Berkeley · US

Funding

Prostate Cancer StudiesZIACP010180 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ALBANES, DEMETRIUS · 2009 to 2025
$9.9M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIA CP010180NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

Age-adjusted mortality rates for prostate cancer are higher for African-American men compared with those of European ancestry. Recent data suggest that West African men also have elevated risk for prostate cancer relative to European men. Genetic susceptibility to prostate cancer could account for part of this difference. We conducted a genome-wide association study (GWAS) of prostate cancer in West African men in the Ghana Prostate Study. Association testing was performed using multivariable logistic regression adjusted for age and genetic ancestry for 474 prostate cancer cases and 458 population-based controls on the Illumina HumanOmni-5 Quad BeadChip. The most promising association was at 10p14 within an intron of a long non-coding RNA (lncRNA RP11-543F8.2) 360 kb centromeric of GATA3 (p = 1.29E-7). In sub-analyses, SNPs at 5q31.3 were associated with high Gleason score (≥7) cancers, the strongest of which was a missense SNP in PCDHA1 (rs34575154, p = 3.66E-8), and SNPs at Xq28 (rs985081, p = 8.66E-9) and 6q21 (rs2185710, p = 5.95E-8) were associated with low Gleason score (<7) cancers. We sought to validate our findings in silico in the African Ancestry Prostate Cancer GWAS Consortium, but only one SNP, at 10p14, replicated at p < 0.05. Of the 90 prostate cancer loci reported from studies of men of European, Asian or African-American ancestry, we were able to test 81 in the Ghana Prostate Study, and 10 of these replicated at p < 0.05. Further genetic studies of prostate cancer in West African men are needed to confirm our promising susceptibility loci.

Indexed as

Genome-Wide Association StudyAfrica, WesternAgedGenetic Predisposition to DiseaseHumansMaleMiddle AgedProstatic Neoplasms

Identifiers

PMID24185611
PMCPMC3988225
OpenAlexW2089010462

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.